Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Down – Here’s Why

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $26.37, but opened at $25.47. Chugai Pharmaceutical shares last traded at $26.5150, with a volume of 8,031 shares changing hands.

Chugai Pharmaceutical Trading Up 0.6%

The stock has a market cap of $87.28 billion, a P/E ratio of 33.15 and a beta of 0.63. The business’s fifty day simple moving average is $26.61 and its 200 day simple moving average is $24.25.

Chugai Pharmaceutical (OTCMKTS:CHGCY) last announced its earnings results on Friday, October 24th. The company reported $0.23 earnings per share (EPS) for the quarter. Chugai Pharmaceutical had a net margin of 32.74% and a return on equity of 20.63%. The company had revenue of $2.26 billion for the quarter. On average, analysts predict that Chugai Pharmaceutical Co., Ltd. Unsponsored ADR will post 0.74 earnings per share for the current fiscal year.

Chugai Pharmaceutical Company Profile

Chugai Pharmaceutical Co, Ltd. is a Japan-based biopharmaceutical company headquartered in Tokyo that focuses on the discovery, development, manufacture and marketing of prescription medicines. The company develops both biologics and small-molecule therapies, with particular emphasis on oncology and immunology as well as treatments for bone and metabolic disorders. Chugai’s activities span the full drug lifecycle from early research and clinical development through regulatory approval, manufacturing and post-marketing support.

Chugai is known for its research-driven approach and its work on monoclonal antibodies and other biologic therapeutics.